News|Articles|October 4, 2024
Quality by Design (QbD) for Biologics: A CDMO's Perspective
Author(s)Catalent
By integrating QbD into the development process, organizations can achieve robust manufacturing processes, regulatory compliance, and commercial success.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
4
Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%
5